Shipp MA - Search Results

1

Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease.

Chapuy B, Cheng H, Watahiki A, Ducar MD, Tan Y, Chen L, Roemer MG, Ouyang J, Christie AL, Zhang L, Gusenleitner D, Abo RP, Farinha P, von Bonin F, Thorner AR, Sun HH, Gascoyne RD, Pinkus GS, van Hummelen P, Wulf GG, Aster JC, Weinstock DM, Monti S, Rodig SJ, Wang Y, Shipp MA. Chapuy B, et al. Among authors: shipp ma. Blood. 2016 May 5;127(18):2203-13. doi: 10.1182/blood-2015-09-672352. Epub 2016 Jan 15. Blood. 2016. PMID: 26773040 Free PMC article.

2

The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen.

Shipp MA, Yeap BY, Harrington DP, Klatt MM, Pinkus GS, Jochelson MS, Rosenthal DS, Skarin AT, Canellos GP. Shipp MA, et al. J Clin Oncol. 1990 Jan;8(1):84-93. doi: 10.1200/JCO.1990.8.1.84. J Clin Oncol. 1990. PMID: 1688615 Clinical Trial.

3

Identification of a second transforming gene, rasn, in a human multiple myeloma line with a rearranged c-myc allele.

Ernst TJ, Gazdar A, Ritz J, Shipp MA. Ernst TJ, et al. Among authors: shipp ma. Blood. 1988 Oct;72(4):1163-7. Blood. 1988. PMID: 3048435 Free article.

4

Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies.

Salles G, Zain M, Jiang WM, Boussiotis VA, Shipp MA. Salles G, et al. Among authors: shipp ma. Blood. 1993 Dec 15;82(12):3539-47. Blood. 1993. PMID: 7505117 Free article.

5

Analysis of the human CD10/neutral endopeptidase 24.11 promoter region: two separate regulatory elements.

Ishimaru F, Shipp MA. Ishimaru F, et al. Among authors: shipp ma. Blood. 1995 Jun 1;85(11):3199-207. Blood. 1995. PMID: 7756651 Free article.

6

Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high-risk" disease?

Shipp MA. Shipp MA. Blood. 1994 Mar 1;83(5):1165-73. Blood. 1994. PMID: 8118021 Free article. Review.

7

Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients.

Kirn D, Mauch P, Shaffer K, Pinkus G, Shipp MA, Kaplan WD, Tung N, Wheeler C, Beard CJ, Canellos GP, et al. Kirn D, et al. Among authors: shipp ma. J Clin Oncol. 1993 Jul;11(7):1336-43. doi: 10.1200/JCO.1993.11.7.1336. J Clin Oncol. 1993. PMID: 8315431

8

CD10/neutral endopeptidase 24.11 is phosphorylated by casein kinase II and coassociates with other phosphoproteins including the lyn src-related kinase.

Ganju RK, Shpektor RG, Brenner DG, Shipp MA. Ganju RK, et al. Among authors: shipp ma. Blood. 1996 Dec 1;88(11):4159-65. Blood. 1996. PMID: 8943850 Free article.

9

The type 2 CD10/neutral endopeptidase 24.11 promoter: functional characterization and tissue-specific regulation by CBF/NF-Y isoforms.

Ishimaru F, Mari B, Shipp MA. Ishimaru F, et al. Among authors: shipp ma. Blood. 1997 Jun 1;89(11):4136-45. Blood. 1997. PMID: 9166856 Free article.

10

A directly spliced exon 10-containing CD44 variant promotes the metastasis and homotypic aggregation of aggressive non-Hodgkin's lymphoma.

Yakushijin Y, Steckel J, Kharbanda S, Hasserjian R, Neuberg D, Jiang W, Anderson I, Shipp MA. Yakushijin Y, et al. Among authors: shipp ma. Blood. 1998 Jun 1;91(11):4282-91. Blood. 1998. PMID: 9596677 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

181 results

Search Page